Mitchell Seyedin, Ph.D., joined ISTO in September 2003 and served as its president and CEO through 2013. Prior to joining ISTO Technologies, Dr. Seyedin was President and CEO of CBYON Inc., a developer and marketer of advanced image-guided surgical systems. In 1995, he founded Orquest, an orthobiologics company that developed biological products for orthopedic applications. He served as Orquest's CEO through 1997, as Chairman through 2001 and as a Board member until its acquisition by Johnson & Johnson in 2003. In 1990, Dr. Seyedin co-founded Metra Biosystems and served as Vice President of Research & Development. In 1995, Metra completed a public offering and was then acquired by Quidel (NASDAQ:QDEL) in June 1999. Before founding Metra, Dr. Seyedin was the Director of Research at Collagen Corporation, where he oversaw responsibility for bone and cartilage research. Dr. Seyedin holds a B.S. in Chemistry from the University of Wisconsin, a Ph.D. in Biochemistry from the University of South Carolina and completed his post-doctoral training at the University of California - Berkeley.
George Dunbar joined ISTO in January 2014. Prior to joining ISTO, Mr. Dunbar was a Venture Partner with Arboretum Ventures. Mr. Dunbar has extensive healthcare operating experience as a former senior executive with a number of venture-backed healthcare companies in the areas of diagnostics, life science tools, and medical devices. Prior to joining Arboretum, Mr. Dunbar was the President, CEO, and Chairman of Aastrom Biosciences (NASDAQ: ASTM), a clinical development stage healthcare company based in Ann Arbor, Michigan. Prior to Aastrom, Mr. Dunbar worked with several national venture capital firms, serving as the CEO of early-stage life science companies, including Quantum Dot (acquired by Invitrogen) and Epic Therapeutics (acquired by Baxter Healthcare). He has also held senior positions in licensing, business development and marketing with the Areas-Serono Group and Amersham International. Mr. Dunbar received a B.S. in Electrical Engineering from Auburn University and a Masters in Business Administration from Auburn University.
John Hart joined ISTO Technologies in July 2012 with over 30 years of medical device and life science experience. Prior to joining ISTO, Mr. Hart was President & CEO of Vidar Systems Corporation, a leading medical imaging company located in Herndon, Virginia, for five years. Prior to 2007, John held senior leadership positions in general management, marketing and sales with Stryker Orthopaedics and U.S. Surgical (now Covidien), including Vice President & General Manager, Vice President of Marketing, and Vice President of Sales. Mr. Hart holds a B.S. degree from The College of New Jersey and an MBA from Southern New Hampshire University.
Scott Gill joined ISTO Technologies in December 2007 with 15 years of investment banking and corporate finance experience. Prior to joining the Company, Mr. Gill was a Director with the Investment Banking group of A.G. Edwards & Sons, Inc. where he worked with a number of public and private emerging growth companies on a variety of corporate finance advisory assignments with a particular emphasis on M&A transactions for clients in the healthcare sector. Before joining A.G. Edwards, Mr. Gill was a Senior Financial Analyst with Anheuser-Busch, Inc. and a commercial banker with Bank of America. Mr. Gill received his Bachelor of Arts in economics from the University of Tennessee and his Master of Business Administration from the J.L. Kellogg School of Management at Northwestern University.
Penny White joined ISTO in May 2000 with 16 years of experience in the biopharmaceutical industry including serving as the Associate Director of Regulatory Affairs for Chiron Corporation, and prior to that as the Associate Director of Technical Affairs for Centocor, Inc. During that time she prepared numerous documents for submission to regulatory bodies, both U.S. and foreign, with successful outcomes leading to product approvals. She is a member of the Regulatory Affairs Professional Society with certification as a Regulatory Affairs Professional, and has a B.S. in Biology from Texas A&M University.
Gary Gage, who joined ISTO in January 2004, has 20 years of experience in the medical device industry. He has developed several products from concept to commercialization, and holds multiple patents. His medical product development tenure includes research and development and senior level management positions with Johnson & Johnson, Surgimedics, Medtronic and Abbott Laboratories. He holds a B.S. in Mechanical Engineering from Texas A&M University and a Master of Business Administration from Auburn University and is a Registered Professional Engineer.